#colorectal surgeons Australia

[walbsc]

Laparoscopic Colorectal and General Surgery in Joondalup, WA

Book an appointment online with top Surgeons in Australia who are experts in Laparoscopic Colorectal, sleeve gastrectomy, and general surgery.The WA Laparoscopic and Bariatric Surgical Centre in Joondalup, WA, is a premier facility specializing in advanced minimally invasive procedures. Our team of experienced surgeons provides comprehensive care in general surgery, offering treatments for conditions like hernias, gallbladder issues, and acid reflux. Utilizing the latest laparoscopic techniques, we ensure reduced recovery times and optimal outcomes for our patients. At our Joondalup location, we are dedicated to delivering personalized, high-quality surgical care in a compassionate and supportive environment. Trust WA Laparoscopic and Bariatric Surgical Centre for your general surgery needs.

WEBSITE: https://www.walbsc.com/laparoscopic-colorectal-and-general-surgery.php

[drnaseem-mirbagheri]

Providing Specialised Haemorrhoid Treatment and Surgery in Melbourne

As one of the only female colorectal surgeons operating in Victoria, Dr Naseem Mirbagheri has spent over 14 years training in hospitals Australia, and holds a PHD in pelvic floor disorders, the findings of which she has presented on national and international stages.

Highly regarded for her patient-focused approach to treatment, Dr Naseem can be found practising surgery in several locations across Melbourne and provides extensive academic and clinical experience in diagnostic and surgical procedures for colorectal and pelvic floor disorders, as well as surgery for haemorrhoids, hernia, and anal fissure repairs.

To organise a consultation with Dr Naseem from her offices in Richmond and Berwick, call 1300 79 50 90.

[cubspaediatricdietetics]

Gastroenterology Specialists | cubspaediatricdietetics.au

Gastroenterology is the branch of medicine that treats digestive disorders such as gastroesophageal reflux disease, irritable bowel syndrome, liver and biliary disease and inflammatory bowel disease.

We investigated the proportion of new patients and follow-up presentations at three public hospital outpatient gastroenterology clinics in Australia. Facility 1 is a tertiary referral centre, facility 2 has specialised IBS, motility, hepatology and transplant hepatology services whereas centre 3 is a public gastroenterology clinic.

Dr Radford-Smith

Dr Radford-Smith is an Australian gastroenterologist who specializes in gut health, inflammatory bowel disease and colorectal neoplasia. He is also an Associate Professor at the University of Queensland and an Honorary Group Leader at the QIMR Berghofer Medical Research Institute.

He is a keen advocate for the utilisation of clinical data in optimising patient care and outcomes. He is also a passionate researcher and has published over 170 articles in the field of gastroenterology.

He leads a team of researchers who have designed a simple clinical tool to help Gastroenterologists triage patients referred for a colonoscopy. They are also developing a novel approach to understanding the role of the microbiome in the development of IBD.

Dr Luke Hourigan

Dr Luke Hourigan is an experienced gastroenterologist who practices privately at Greenslopes Private Hospital (associate of Queensland Gastroenterology). He has a specialist interest in the management of Barrett's oesophagus and large colonic polyps.

He is a member of the Australian Gastroenterology Endoscopic Association and serves on the education committee of the World Endoscopy Organization. He is also an active participant in the NETI National Colonoscopy Training Initiative.

A/Professor Hourigan is a past President of the Gastroenterology Society of Queensland and an Honorary Clinical Professor at the University of Queensland. He has been involved in gastrointestinal endoscopy training and research for many years and has a particular interest in the use of advanced endoscopic techniques to manage premalignant and malignant lesions.

He has extensive experience in the diagnosis, management and treatment of gastrointestinal disorders including inflammatory bowel disease and hepatitis. He is a leading authority in the field of endoscopic management of diseases of the oesophagus, stomach, small intestine and pancreas.

Dr Michael Payne

Dr Michael Payne is a gastroenterologist at queensland gastroenterology who treats digestive problems such as acid reflux, stomach pain, constipation, Crohn’s disease and ulcers. He also offers cancer treatment using radiation therapy, which can reduce the number of treatments required and improve quality of life for patients with advanced cancers.

Dr Payne completed his undergraduate degree in Mechanical Engineering at Queens University before completing a Master’s degree in Sports Medicine. He then went on to complete a medical degree and residency training in physical medicine and rehabilitation at the University of Ottawa, followed by a clinical fellowship in Australia.

As a radiation oncologist, Dr Payne treats patients with cancer of all types and works to ensure that they receive the best possible care and are treated as individuals. He believes that diet, lifestyle and attitude can play a role in determining the success of cancer treatment. As a result, he makes sure that each patient understands what to expect during treatment and helps them make informed decisions about their health.

Dr Peter MacDonald

Dr Peter MacDonald is a g gastroenterology specialist at queensland gastroenterology who is interested in gastrointestinal surgery, including coloproctology. He is also a medical writer and has published several books. He is a member of the Royal College of Surgeons and the London Gastroenterological Society.

He is a former President of the International Association for the Study of the Liver and a Founding Editor of the Journal of Gastroenterology and Hepatology. He was also the first recipient of the GESA Distinguished Research Prize.

Australian Hepatology has been blessed with a number of leading hepatic pathologists who have made significant contributions and achieved world recognition. These include the late Pauline Hall (alcoholic liver disease),63 Andrew Clouston (steatohepatitis and the ductular reaction referred to above) and Prithi Bhathal who has contributed greatly in the field of portal hypertension and cirrhosis.

[bobbykingston]

Colorectal surgeon performs colonoscopy to examine the changes that is happening in the large intestine. Best colorectal surgeon in Sydney is expert in conducting all types of colorectal tests.

 http://colorectal-surgeon.com.au/

[catherinedmccracken]

August 2020 Learning Network Resources

Tuesday, September 15, @ 4:00 PM EST

Please join us for a webinar on Delaware’s statewide Choosing Wisely inspired advanced illness collaboration with speaker Dr. Rob Dressler, quality and safety officer at Christiana Care. Register in advance for this meeting.

  Blogs, Issue Briefs, Opinion Pieces and More…

Pediatric Advanced Imaging: When Is Less More? MedPage Today. August 2020 “For example, physicians may feel pressured to make a timely diagnosis within an ED visit, or don’t want to risk malpractice for missing a diagnosis, Marin said. ‘A family comes to the ED with their child’s symptom or condition and they’ve waited for several hours and paid a copay,’ Marin said. ‘It can be challenging to not do a test and to ask them to do what we call ‘watchful waiting.’ As a society, we have less tolerance for that today than we have in the past.’”

  Analysis: When Is a Coronavirus Test Not a Coronavirus Test? Kaiser Health News. July 2020 “Coronavirus testing in the United States has been bungled in every way imaginable. The latest fiasco is perhaps the most Kafkaesque: Tests are now widely available in many places, but results are often taking so long to come back that it is more or less pointless to get tested.”

  Covid-19: an opportunity to reduce unnecessary healthcare. BMJ. July 2020 “This pandemic has provoked the best of human compassion and solidarity, but those who manage our health systems still face extraordinary challenges responding to covid-19 and preparing for the second wave. Looking beyond the crisis, our collective learning about the effects of the large falls in healthcare use can help inform and intensify efforts to reduce unnecessary care. This in turn can prevent avoidable harm to patients, enhance healthcare equity, and improve the sustainability of health systems everywhere.”

  Journals

McKay VR, et alt. Better Service by Doing Less: Introducing De-implementation Research in HIV. Implementation Science. August 2020 “The course of HIV research has led to a multitude of interventions to prevent and treat HIV. With the arrival of more effective interventions comes the need to end, or de-implement, less effective interventions. Existing studies have identified a set of HIV-specific interventions appropriate for de-implementing and described the persistence of interventions that should be ended. However, to our knowledge, strategies to successfully promote appropriate de-implementation of HIV-specific interventions have not been examined. De-implementing interventions that are no longer needed is an opportunity to improve the quality and effectiveness of HIV services. Opportunities to expand this field of research abound.”

  Chen DW, et alt. Physician-Reported Misuse of Thyroid Ultrasonography. JAMA Surgery. August 2020 “In the US, there is an ongoing national dialogue about avoiding unnecessary medical tests, with the Choosing Wisely campaign recommending against ordering thyroid ultrasonographic examinations for abnormal thyroid function test results. However, despite this national dialogue, little is known about physician-reported use of thyroid ultrasonography, a known driver of thyroid cancer incidence.”

  Okereke OI, et alt. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores – A Randomized Clinical Trial. JAMA. August 2020 “Among adults aged 50 years or older without clinically relevant depressive symptoms at baseline, treatment with vitamin D3 compared with placebo did not result in a statistically significant difference in the incidence and recurrence of depression or clinically relevant depressive symptoms or for change in mood scores over a median follow-up of 5.3 years. These findings do not support the use of vitamin D3 in adults to prevent depression.”

  Leventer‐Roberts M, et alt. Choosing Wisely: Determining Performance of Unjustified Imaging in a Large Healthcare System. International Journal of Clinical Practice. August 2020 “Overall, this study found that diagnostic imaging practices are applied inconsistently by hospital and by population. Intervention efforts should be focused on subpopulations at greatest risk to further reduce exposure to such imaging.”

  Moss JL, et alt. Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults. JAMA. July 2020 “In this study, overscreening for cancer among older adults was high, particularly for women living in metropolitan areas. Overscreening could be associated with health care access and patient-clinician relationships. Additional research on why overscreening persists and how to reduce overscreening is needed to minimize risks associated with cancer screening among older adults.”

  Media Coverage

10 Ways to Improve Patient Interactions While Wearing a Mask. Medpage Today. August 2020 “Our hope is that these 10 strategies reassure clinicians who are feeling exhausted and frustrated by the communication challenges while wearing a mask that there are many ways to connect with patients when genuine smiles and sympathetic touch are restricted. Any combination of these strategies can help you provide compassionate care from behind a mask.”

  Episode 11: Are you Choosing Wisely during the pandemic? NPS Medicinewise. August 2020 “In this episode, Steve Morris speaks with Dr Simon Judkins, an emergency physician working in Victoria at one of the Choosing Wisely Australia Champion Health Service hospitals. They discuss how the Choosing Wisely principles, particularly around resource stewardship and the importance of conversations about what care is necessary, have been relevant during the COVID-19 pandemic. They also look at how new pandemic guidance from Choosing Wisely Australia will help health professionals and consumers navigate the current environment.”

  Physicians urge peers to quash ‘low value’ use of daily chest x-rays in the ICU. Radiology Business. July 2020 “Advances in technology, such as ultrasound and modern ventilators that closely monitor pulmonary mechanics, have further rendered daily CXR moot. The writers suggested solutions such as ICU policy changes, evidence-based education and clinician engagement to begin addressing this issue. The practice can continue in certain specific scenarios, they added, including monitoring certain catheters, but largely this practice should disappear. ‘CXRs should otherwise be reserved for specific clinical concerns, such as new hypoxemia,’ Maley and Stevens said. ‘By eliminating the need to review daily CXRs for each patient, clinicians may also increase time spent at the bedside and focus on higher-value data that meaningfully inform care,’ they added.”

  Christopher Labos: The pandemic’s lessons for health-care spending. The Province. July 2020 “One of the interesting things I hope we take away from the pandemic is that much of the routine care we offer up to patients may not be necessary. Many patients had their routine follow-ups delayed by a few months or converted into telemedicine visits, and were no worse off as a result. While COVID-19 claimed many lives not only directly, but indirectly by delaying important medical care, it may also have shown us that a lot of our medical care is unnecessary. If we can trim the fat of unnecessary medical testing, then we may better secure our health-care system to face the challenge of our aging population.”

  The Knee Surgeon Was In-Network. The Surgical Assistant Wasn’t, And Billed $1,167. NPR. July 2020 “As hospitals across the country restart elective surgeries, patients should be aware of this common pitfall — and realize it’s a fee they may have no recourse but to pay if their state doesn’t have protections against surprise billing.”

   The post August 2020 Learning Network Resources first appeared on Choosing Wisely.

      Related Stories

August Learning Network Resources

  https://feeds.feedblitz.com/~/634611426/0/catherinemccracken~August-Learning-Network-Resources/

[datainsightspartner-blog]

Report Description

A recent market intelligence report that is published by Data Insights Partner on the global Robotic Surgery market makes an offering of in-depth analysis of segments and sub-segments in the regional and international  Robotic Surgery   market. The research also emphasizes on the impact of restraints, drivers, and macro indicators on the regional and global Robotic Surgery market over the short as well as long period of time. A detailed presentation of forecast, trends, and dollar values of global Robotic Surgery market is offered. In accordance with the report, the global Robotic Surgery market is projected to expand at a CAGR of 9% over the period of forecast.

Market Insight, Drivers, Restraints& Opportunity of the Market:

Robotic surgery is one types of minimally invasive surgeries which is performed to overcome pre-existing problems during complicated surgeries. It has integrated the advanced computer technology and experience of surgeons and provides the surgeons greater precision and flexibility.

The global Robotic Surgery market is primarily driven by the increasing adoption of minimally invasive surgeries across worldwide. According to a study published in Yonsei Medical Journal, published in 2018, more than 10,000 robotic surgeries (da Vinci robotic procedure) were performed in a single health institute in South Korea between the period July 2005 and December 2013. One of the spokespersons from the Intuitive Surgical, Inc. informed that the number of da Vinci procedures per year reached to 877,000 in 2017 from 136,000 in 2008.

On the contrary, the growth of the global Robotic Surgery market may be hampered by less awareness about the true cost of robotic surgery across worldwide. One of the renowned health economists from the University of California, confirmed that most clinicians and administrators do not have idea about the true cost of the robotic surgeries and the cost which was previously estimated is not accurate. Other barrier for the growth of the global Robotic Surgery market is technical difficulty during surgery.

Mergers and acquisitions/joint ventures among key market players, technological advancements etc. will open up the global Robotic Surgery market to grow over the forecast period. For example, Medtronic acquired Mazor Robotics and its proprietary robotic guidance system for spine surgery in 2018. The US$ 1.6 Bn deal was made in order to advance the spine surgery with the guidance of robotic system, confirmed by the VP of the Restorative Therapies Group, Medtronic. Furthermore, Intuitive Surgical acquired the robotic endoscopy business of Schölly Fiberoptic in 2019 whereas the acquisition is expected to provide Intuitive Surgery high quality maintenance and repair business of robotic endoscope products in upcoming future.

Request For Report Sample Click Here

https://datainsightspartner.com/request-for-sample?ref=26

Segment Covered:

This market intelligence report on the global Robotic Surgery market encompasses market segments based on practice area, organ, end user and geography. On the basis of practice area, the sub-market is segmented gastroenterology, urology, gynecology, ENT, Neurology, and other . Based on organ, the global Robotic Surgery market is categorized into thyroid, prostate, stomach, colorectal, kidney/uterus, head and neck, thoracic, others. In terms of end user, the global Robotic Surgery market has been segregated into hospitals and ambulatory surgery centers, and clinics. By Geography, the global Robotic Surgery  market has been divided into North America (the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other countries), Asia Pacific (India, Japan, China, Australia and New Zealand and other countries), Middle East and Africa (GCC, South Africa, Israel and Other countries).

Profiling of Market Players:

This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as Medtronic, Intuitive Surgical, Stryker, Smith and Nephew, Zimmer Biotech, Auris Surgical Robotics, Renishaw, Curexo Technology, Transenterix, Medrobotics, and others have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as robotic surgery related investment & spending and developments by major players of the market are tracked in this global report.

Report Highlights:

In-depth analysis of the micro and macro indicators, market trends, and forecasts of demand is offered by this business intelligence report. Furthermore, the report offers a vivid picture of the factors that are steering and restraining the growth of this market across all geographical segments. In addition to that, IGR-Growth Matrix analysis is also provided in the report so as to share insight of the investment areas that new or existing market players can take into consideration. Various analytical tools such as DRO analysis, Porter's five forces analysis has been used in this report to present a clear picture of the market. The study focuses on the present market trends and provides market forecast from the year 2017-2027. Emerging trends that would shape the market demand in the years to come have been highlighted in this report. A competitive analysis in each of the geographical segments gives an insight into market share of the global players.

To know more detailed information of Report Click Here

https://datainsightspartner.com/report/robotic-surgery-market/26

Salient Features:

Ø This study offers comprehensive yet detailed analysis of the  Robotic Surgery market, size of the market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of forecast: 2019 – 2027, taking into account 2018 as the base year

Ø It explains upcoming revenue opportunities across various market segments and attractive matrix of investment proposition for the said market

Ø This market intelligence report also offers pivotal insights about various market opportunities, restraints, drivers, launch of new products, competitive market strategies of leading market players, emerging market trends, and regional outlook

Ø Profiling of key market players in the world Robotic Surgery market is done by taking into account various parameters such as company strategies, distribution strategies, product portfolio, financial performance, key developments, geographical presence, and company overview

Ø Leading market players covered this report comprise names such as Medtronic, Intuitive Surgical, Stryker, Smith and Nephew, Zimmer Biotech, Auris Surgical Robotics, Renishaw, Curexo Technology, Transenterix, Medrobotics and among others

Ø The data of this report would allow management authorities and marketers of companies alike to take informed decision when it comes to launch of products, government initiatives, marketing tactics and expansion, and technical up gradation

Ø The world market for surgical robotics caters to the needs of various stakeholders pertaining to this industry, namely suppliers, manufacturers, investors, and distributors for surgical robotics market. The research also caters to the rising needs of consulting and research firms, financial analysts, and new market entrants

Ø Research methodologies that have been adopted for the purpose of this study have been clearly elaborated so as to facilitate better understanding of the reports

Ø Reports have been made based on the guidelines as mandated by General Data Protection Regulation

Ø Ample number of examples and case studies have been taken into consideration before coming to a conclusion

Reasons to buy:

v Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the global Robotic Surgery   market

v Identification of key factors driving investment opportunities in the Robotic Surgery market

v Facilitate decision-making based on strong historic and forecast data

v Position yourself to gain the maximum advantage of the industry’s growth potential

v Develop strategies based on the latest regulatory events

v Identify key partners and business development avenues

v Respond to your competitors’ business structure, strategy and prospects

[bsnbooks-blog]

Colorectal Cancer Risk Factors

Consult the best colorectal surgeon in Sydney, Australia. Alfred colorectal  Surgeons Sydney are well equipped and specialized in dealing with all types of disorders affecting the colon, rectum, and anus.

http://alfredcolorectalsurgery.com.au/

[winnettspecialist-blog]

Mr Jason Winnett is a weightloss surgeon Melbourne. He offers robotic technology to assist in gastric bypass surgery. He is guided to you every step of the weight loss through the process. For more details, visit at https://winnettspecialistgroup.com.au/

[bobbykingston]

Best colorectal surgeons from Sydney, Australia can assist you with all kinds of colorectal disorders which affects your colon, rectum and anus. Consult colorectal surgeon for more information.

http://colorectal-surgeon.com.au/

[colorectalsurgeonsydney-blog]

Colorectal Surgeon Sydney

Colorectal cancer is cancer that starts in the colon or the rectum, also known as colon cancer or rectal cancer. Colorectal cancer is a very common cancer in Australia. It affects about 1 in 20 persons in Australia.

http://colorectal-surgeon.com.au/

[kiransable07]

Cancer diagnostics market outlook, regional growth & industry share by 2026

A research study conducted by Global Market Insights, Inc., suggests that Cancer Diagnostics Market is likely to exceed the $170 billion mark by 2025, in terms of revenue. Growing awareness regarding early disease diagnosis coupled with increasing number of diagnostic and research laboratories will drive cancer diagnostics market demand over the forthcoming time period. Evolving healthcare infrastructure of developing countries, rising awareness about cancer, and increasing healthcare spending will further influence the market growth positively.

With growing prevalence of cancer cases across the globe, key industry players are increasingly focusing on consolidating their position in the market through several tried-and-tested methods. Citing an instance, on 29th June 2020, BioCare Medical, a renowned provider of automated, innovative, immunohistochemistry (IHC) instrumentation and reagents, reportedly announced a collaborative partnership with Bethyl Laboratories for developing targeted antibodies for oncology diagnostics and cancer research. This partnership will further provide BioCare strong synergy to accelerate research antibodies of Bethyl into the clinical market space.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/2406

 Myriad usage across many industries, such as healthcare, manufacturing, and food & beverage Based on type, the rectal and colon and cancer segment is expected to observe substantial growth over the projected time period. It is likely to reach a valuation of over $16.9 billion by the end of the analysis timeframe. Increasing incidence of colorectal cancer amongst young adults has further raised the demand for rectal and colon cancer diagnostic products. As per the American Cancer Society, since 1994 cases of colorectal cancer in individuals aged under 50 years has increased by 51%. In fact, nearly 16,000 people aged below 50 years are diagnosed with colorectal cancer annually, stimulating the demand for disease monitoring diagnostic kits.

In terms of end-use, in 2018, the cancer research institutes segment was valued at approximately $6.4 billion and is expected to experience rapid growth over the forecast timeframe. The growth is being ascribed to investments by market players looking to accelerate research activities regarding cancer diagnosis owing to the increasing demand for advanced cancer diagnostic tools. Key companies operating in the market are also joining forces with research institutes to reinforce their R&D as well as advanced new product development processes, which will further drive segmental growth.

In addition, there is need for new technologies that could be applied in the operating room for helping surgeons by providing them with the information on the absence or presence of cancer at specific position of the body. In that regard, mass-spectrometry based techniques are picking up traction as they prove to be extremely helpful for improving the diagnosis and monitoring of patients with cancer.

Request for customization @ https://www.gminsights.com/roc/2406

Through a regional perspective, the Germany cancer diagnostics industry is anticipated to witness more than 9.0% CAGR over the estimated timeframe. Substantial expenditure on healthcare along with high technological adoption will fuel the cancer diagnostics market growth in the region. Furthermore, as the risk of various type of cancer increases with age, the region’s increasing geriatric population base will drive Germany cancer diagnostics segment growth in the coming years.

The competitive landscape of caner diagnostics market includes Qiagen, Siemens Healthcare, Sysmex Corporation, Hologic, bioMerieux, Abbott Laboratories, Cancer Genetics, Bio-Rad Laboratories, Biocartis, Dickinson and Company (BD), Roche, Alere, Becton, GE Healthcare, and BioCare Medical among others.

Browse key industry insights spread across 244 pages with 257 market data tables & 16 figures & charts from the report, “Cancer Diagnostics Market Size, By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Russia, Japan, China, India, Australia, Mexico, Brazil, Argentina, South Africa, UAE, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/cancer-diagnostics-market

About Global Market Insights:

 Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

 Contact Us:

Arun Hegde

Corporate Sales, USA

Global Market Insights, Inc.

Phone:1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com/

[nrip]

Patterns of internet and social media use in colorectal surgery 

Background

Surgeons use the Internet and social media to provide health information, promote their clinical practice, network with clinicians and researchers, and engage with journal clubs and online campaigns. While surgical patients are increasingly Internet-literate, the prevalence and purpose of searching for online health information vary among patient populations. We aimed to characterise patient and colorectal surgeon (CRS) use of the Internet and social media to seek health information.

Methods

Members of the Colorectal Society of Australia and New Zealand and patients under the care of CRS at the Royal Prince Alfred Hospital, Sydney, were surveyed. Questions pertained to the types of information sought from the Internet, the platforms used to seek it, and the perceived utility of this information.

Results

Most CRS spent 2–6 h per week using the Internet for clinical purposes and an additional 2–6 h per week for research. 79% preferred literature databases as an information source. CRS most commonly directed patients to professional healthcare body websites. 59% of CRS use social media, mainly for socialising or networking. Nine percent of surgeons spent > 1 h per week on social media for clinical or research purposes. 72% of surgeons have a surgical practice website.

43% of patients searched the Internet for information on their doctor, and 75% of patients sought information on their symptoms or condition. However, 25% used health-specific websites, and 14% used professional healthcare body websites. Around 84% of patients found the information helpful, and 8% found it difficult to find information on the Internet. 12% of patients used social media to seek health information.

Conclusions

Colorectal surgery patients commonly find health information on the Internet but social media is not a prominent source of health information for patients or CRS.

[gastrosurgerysurat]

Colorectal Cancer – A Cure is possible

Colorectal Cancer (CRC) is a common and potentially lethal disease. Globally, CRC is the third most commonly diagnosed cancer in males and the second in females, with 1.65 million new cases and almost 835,000 deaths in 2015. As per GLOBOCON (2012) data, incidence of CRC in India is very low (Age Standardize rate per 1,00,000 – 6.09) as compared to Australia (38), New Zealand (37), Europe (30), North America (25), Canada (31) and other countries of South East Asia. However, with increase in urbanization there is a steady increase in incidence of CRC in India.

Know the Risk Factors associated with Colon Cancer

Risk factors can be broadly divided into genetic and environmental reasons. Genetic syndromes include familial adenomatous polyposis (FAP), Hereditary nonpolyposis colon cancer (HNPCC) or Lynch syndrome, Turcot, Gardner and MyH-associated polyposis. Environmental factors include consumption of alcohol, fresh red meat, processed meat, obesity, smoking, ulcerative colitis, old age, male gender and diabetes mellitus with insulin resistance.

Learn the Common Symptoms of Colorectal Cancer

Patients with symptoms such as melena (black stool), bleeding per rectum, chronic anemia, alternate diarrhea & constipation, passage of mucus in stool, tenesmus and constitutional symptoms like weakness, anorexia, weight loss & fever. In case of obstructing tumors (left colon) presentation can be with severe abdominal pain, distention, vomiting and obstipation.

How to Diagnose Colorectal Cancer?

>>Blood tests include complete blood count (CBC), liver & kidney function tests, carcinoembryonic antigen (CEA) and carbohydrate antigen 19.9 (CA19.9). Preoperative CEA & CA19.9 levels help in prognostication and is necessary for follow up to detect/identify recurrence.

>>Colonoscopy is necessary to identify extent of disease and also to detect other synchronous (2-5%) lesions if any. It also helps to take preoperative biopsy.

>>Radiological imaging in form of contrast enhanced computed tomography (CECT) scan of abdomen is necessary for staging. Magnetic resonance imaging (MRI) is better for rectal cancer.

What is the Effective Treatment for CRC?

Multi-disciplinary team (MDT) approach is necessary for effective treatment of CRC. MDT consists of CRC Surgeon, Gastroenterologist, Medical Oncologist, Radiation specialist, Pathologist, Radiologist & nurse.

Broadly options include following:

a.Early or Operable Disease: Primary surgery with or without adjuvant chemotherapy or radiotherapy (for rectal cancer).

b.Locally Advanced Disease: Primary surgery unlikely: Consider preoperative chemotherapy/radiotherapy

c.Isolated metastatic disease: Consider resection of primary disease followed by metastatectomy with or without neoadjuvant and/or adjuvant chemotherapy

d.Widespread metastatic disease: Palliative chemotherapy, supportive care

What is the Surgery for Treating Colon Cancer?

Surgery forms mainstay in curative treatment of colorectal cancer. Principles of surgery for primary tumor are as follows:

>>For colon cancer: Complete Mesocolic Excision (CME) with central vessal ligation (CVL) should be done in which the affected part of the colon and at least a 5-cm segment on either side together with the draining lymph nodes along the feeding vessels should be resected.

>>For rectal cancer: A distal margin of 1–2 cm may be acceptable for low rectal cancers.  Total Mesorectal Excision (TME) extending 4–5 cm below the distal edge of the tumour/complete TME should be performed.

>>A minimum lymph node yield of 12 is required for adequate staging.

>>Laparoscopy-assisted/Laparoscopic resection may be considered by experienced laparoscopic surgeons for uncomplicated early disease.

Principles of Surgery for Colorectal Liver Metastasis (CLM) are:

1. Liver resection is the treatment of choice for resectable CLM.

2. Preoperative assessment for resectability must be performed according to the location and extent of hepatic disease as well as adequacy of future liver remnant (FLR).

3. When the FLR is inadequate, portal venous embolization or staged liver resection can be considered.

4. The primary tumor must be resectable/completely resected (R0)

5. For synchronous liver metastasis, simultaneous resection or a staged approach can be adopted depending on the anticipated complexity of surgery of the primary tumor and of the liver disease, available surgical expertise, and co-morbidities.

6. For upfront unresectable cases, re-evaluation for conversion to resectable disease should be considered every 2 months after preoperative chemotherapy, provided all original sites are amenable to resection.

Chemotherapy and Radiotherapy

Commonly used chemotherapy 5-Flourouracil with Oxaloplatin (FOLFOX) or Capecitabine with Oxaloplatin (CapeOx) as adjuvant treatment for stage III, IV and selected stage II CRC. Patients with stage II and above rectal cancer require preoperative or postoperative CTRT (combination chemoradiotherapy).

Prognosis

Amongst all digestive cancers, this cancer carries the best prognosis largely due to the multidisciplinary treatment options that have dramatically improved over the last decade. Overall, 5-year survival rates of CRC for Stage I is 88-92%, Stage II is 60-85%, Stage III is 50-80% and Stage IV is 12-13%.

Seek an experienced GI Surgeon for colorectal cancer treatment. Visit an expert to know more about colon cancer and other ailments of the digestive system. Call on +91-9016519832 to book an appointment with the best gastrointestinal surgeon in Surat.